Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Director/PDMR Notification

18 Sep 2020 09:47

RNS Number : 4313Z
Scapa Group PLC
18 September 2020
 

18 September 2020

LEI No. 213800QIPVTK5ES5UU36

SCAPA GROUP PLC

('the Company')

 

Director/PDMR Notification

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ('PDMR')

Scapa Group plc (AIM: SCPA) today announces that on 16 September 2020, the PDMRs named below were each granted nil cost options, under the Scapa Group plc 2019 Long Term Incentive Plan ('LTIP'), in respect of the number of ordinary shares of 5p each ('Ordinary Shares') shown alongside their respective names.

 Name / Position of PDMR

Number of Ordinary Shares over which the option is held

Oskar Zahn - Chief Financial Officer

300,172

John Petreanu - President Healthcare

254,113

Brett Pollard - MD Global Corporate Dev & Strategy

75,043

Wendy Baker - Group General Counsel and CoSec

145,798

In accordance with the rules of the LTIP, no consideration was paid by the above-named individuals for the option granted to him/her. Each option is subject to, and governed by, the rules of the LTIP and the legislation relating to the LTIP.

This announcement, including the notifications below, is made in accordance with the requirements of the EU Market Abuse Regulation.

ANNEX

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Oskar Zahn

 

2

Reason for the notification

 

a)

Position / status

Chief Financial Officer

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

a)

Description of financial instrument,

type of instrument

Ordinary Shares of 5p each

 

Identification Code

 

GB0007281198

b)

Nature of the transaction

Grant of share option

 

c)

Price(s) and volume(s)

 

300,172 Ordinary Shares

Exercise price 0p

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

16 September 2020

 

f)

Place of the transaction

Off Market

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

John Petreanu

 

2

Reason for the notification

 

a)

Position / status

President, Healthcare

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

a)

Description of financial instrument,

type of instrument

Ordinary Shares of 5p each

 

Identification Code

 

GB0007281198

b)

Nature of the transaction

Grant of share option

 

c)

Price(s) and volume(s)

 

254,113 Ordinary Shares

Exercise price 0p

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

 

16 September 2020

f)

Place of the transaction

 

Off Market

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Brett Pollard

 

2

Reason for the notification

 

a)

Position / status

MD, Global Corp Development & Strategy

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

a)

Description of financial instrument,

type of instrument

Ordinary Shares of 5p each

 

Identification Code

 

GB0007281198

b)

Nature of the transaction

Grant of share option

 

c)

Price(s) and volume(s)

 

75,043 Ordinary Shares

Exercise price 0p

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

 

16 September 2020

f)

Place of the transaction

 

Off Market

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Wendy Baker

 

2

Reason for the notification

 

a)

Position / status

Group General Counsel and CoSec

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

a)

Description of financial instrument,

type of instrument

Ordinary Shares of 5p each

 

Identification Code

 

GB0007281198

b)

Nature of the transaction

Grant of share option

 

c)

Price(s) and volume(s)

 

145,798 Ordinary Shares

Exercise price 0p

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

 

16 September 2020

f)

Place of the transaction

Off Market

 

 

 

For further information:

 

Scapa Group plc:

Wendy Baker +44 (0) 161 301 7400

Company Secretary

 

Numis Securities Limited: +44 (0) 20 7260 1000

Mark Lander/Freddie Barnfield

(Joint Broker/Nominated Adviser)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUWSWRRSUKARR
Date   Source Headline
2nd Jul 20184:33 pmRNSTotal Voting Rights
28th Jun 20184:12 pmRNSDirector/PDMR Shareholding
5th Jun 20184:00 pmRNSDirector/PDMR Shareholding
31st May 201810:31 amRNSTotal Voting Rights
30th May 201810:20 amRNSDirector/PDMR Shareholding
22nd May 20187:00 amRNSFinal Results
30th Apr 201810:30 amRNSTotal Voting Rights
12th Apr 20187:00 amRNSTrading Statement
11th Apr 20183:29 pmRNSIncident at Dunstable Site
29th Mar 201811:48 amRNSTotal Voting Rights
26th Mar 20187:00 amRNSAcquisition
28th Feb 20181:38 pmRNSTotal Voting Rights
7th Feb 20189:17 amRNSBlock listing Interim Review
31st Jan 20189:08 amRNSTotal Voting Rights
25th Jan 20182:14 pmRNSBlock listing Interim Review
8th Jan 201810:10 amRNSDirectorate Change
7th Dec 20173:52 pmRNSDirector/PDMR Shareholding
7th Dec 20173:49 pmRNSAdditional Listing
29th Nov 201711:15 amRNSDirector/PDMR Shareholding
28th Nov 20172:56 pmRNSDirector/PDMR Shareholding
28th Nov 20172:44 pmRNSDirector/PDMR Shareholding
23rd Nov 20179:36 amRNSDirector/PDMR Shareholding
21st Nov 20177:00 amRNSHalf-year Report
17th Nov 201710:22 amRNSAdditional Listing
11th Oct 20177:00 amRNSTrading Statement
4th Oct 20177:00 amRNSCapital Markets Day
26th Sep 201711:38 amRNSAdditional Listing
21st Sep 20174:21 pmRNSHolding(s) in Company
8th Sep 201711:31 amRNSDirector/PDMR Shareholding
4th Sep 20173:18 pmRNSDirector/PDMR Shareholding
4th Sep 201710:13 amRNSAdditional Listing
25th Aug 20177:00 amRNSDirector/PDMR Shareholding
17th Aug 20174:14 pmRNSDirector/PDMR Shareholding
11th Aug 20174:12 pmRNSDirector/PDMR Shareholding
9th Aug 20177:00 amRNSAcquisition
7th Aug 20171:56 pmRNSBlock listing Interim Review
25th Jul 201710:09 amRNSBlock listing Interim Review
19th Jul 20179:29 amRNSHolding(s) in Company
18th Jul 20177:00 amRNSAGM Statement
1st Jun 20171:59 pmRNSHolding(s) in Company
30th May 20172:09 pmRNSAdditional Listing
23rd May 20177:00 amRNSFinal Results
18th May 20173:47 pmRNSHolding(s) in Company
17th May 20173:36 pmRNSHolding(s) in Company
3rd May 201710:31 amRNSAdditional Listing
21st Apr 20179:41 amRNSHolding(s) in Company
19th Apr 20173:33 pmRNSAdditional Listing
13th Apr 20177:00 amRNSTrading Statement
27th Mar 20172:05 pmRNSDirector/PDMR Shareholding
23rd Mar 201711:46 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.